|
|
 |
|
Viewing report
|
|
|
|
Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review
GlobalData, Feb 2012, Pages: 47
Emergent BioSolutions Inc. (EBS) - Financial and Strategic SWOT Analysis Review
Summary
Emergent BioSolutions Inc. (Emergent) is a biopharmaceutical company, involved in the development, manufacture and marketing of immunobiotic product candidates including vaccines and therapeutics that assist the patient's immune system to treat disease. The company’s principal product, BioThrax was approved by the US FDA for the prevention of anthrax infection. Emergent's various products under development targets botulism, anthrax, tuberculosis, hepatitis B, typhoid and chlamydia. The company develops its products based on the platform technologies include spi-VEC, MVAtor, SMIP therapeutics, SCORPION therapeutics and TRU-ADhanCe technology. It primarily operates through two reportable segments, namely, Biodefense and Biosciences. Emergent operates its business through 20 subsidiaries across the US, Germany, the UK, Malaysia, Australia and Singapore.
The company’s strategy is to establish a market for sales of BioThrax to customers including foreign governments and state and local governments, in addition to the US government. Since inception, Emergent has pursued a strategy of growing its business through licensing and acquisition. Emergent is headquartered in Rockville, Maryland, the US.
Emergent BioSolutions Inc. Key Recent Developments
Dec 21, 2011: Emergent BioSolutions Announces Fuad El-Hibri to Retire as CEO
Dec 21, 2011: Emergent Announces Fuad El-Hibri To Retire As CEO
Nov 03, 2011: Emergent BioSolutions Reports Revenues Of $58.8m In Q3 2011
Aug 04, 2011: Emergent BioSolutions Reports Total Revenue Of $88.1m In Q2 2011
May 05, 2011: Emergent BioSolutions Reports Net Loss Of $21.4m For Q1 2011
This comprehensive SWOT profile of Emergent BioSolutions Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Key Words
Emergent BioSolutions Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Customers who bought this item also bought
Emergent BioSolutions Inc. - Product Pipeline Review - H2 2011
Emergent BioSolutions Inc. - Product Pipeline Review - 2012
Emergent BioSolutions Inc. - Product Pipeline Review - Q4 2010
Emergent BioSolutions Inc. - Product Pipeline Review - Q4 2010
BioSante Pharmaceuticals, Inc. (BPAX) - Financial and Strategic SWOT Analysis Review
BioCryst Pharmaceuticals, Inc. (BCRX) - Financial and Strategic SWOT Analysis Review
DARA BioSciences, Inc. (DARA) - Financial and Strategic SWOT Analysis Review
Advanced BioHealing, Inc. - Strategic SWOT Analysis Review
Soligenix, Inc. (SNGX) - Financial and Strategic SWOT Analysis Review
AVI BioPharma Inc. (AVII) - Financial and Strategic SWOT Analysis Review
|
|
|
|
